Harsha Reddy Borra is a bioprocessing leader with over 18 years of experience in biologics development and manufacturing, spanning monoclonal antibodies, complex proteins, and advanced therapies, including viral vectors. As Group Leader of Biosimilars Development at Accord Healthcare, he drives bioprocess innovation, automation, and technology transfer. Borra's expertise covers biologics, biosimilars, and cell and gene therapy modalities, integrating advanced analytics, PAT, and sustainable biomanufacturing to enable efficient, compliant, and scalable processes.